Crossmark

Cocktails of KLK5 Protease Inhibitors and Anti-TNFα Therapeutics: an Effective Treatment for Netherton Syndrome

Published Online: 2022-01-18

Published Print: 2022-04

Authors

Zingkou, Eleni

Pampalakis, Georgios

Sotiropoulou, Georgia https://orcid.org/0000-0003-0747-4914
License Information

Text and Data Mining valid from 2022-01-18

Version of Record valid from 2022-01-18
More Information

Article History

Received: 27 August 2021

Accepted: 7 December 2021

First Online: 18 January 2022

Declarations

:

: All experiments with animals were carried out in accordance with the EU and national legal and ethical regulations following governmental approval of the experimental protocol (Veterinary Department of Regional Units of Achaia, Region of Western Greece).

: Not applicable.

: All authors have approved the final version of the manuscript.

: The authors declare no competing interests.

Document is current